Based on published literature and extensive research that we conducted on symptomatic and asymptomatic patients and a variety of pulmonary upper tract diseases and infection, Breath of Health has been able to identify the specific COVID19 markers. We filtered all additional markers that were present due to other conditions, and background diseases such as diabetes etc. By cross-referencing and analysis of the data, we are able to identify several wavelengths in the FTIR that are the most important for identification of a COVID19 Infection.
Clinical research is an ongoing effort at Breath of Health.
Breath of Health is currently conducting clinical trials, which have been approved by the Ministry of Health at Shiba Tel Hashomer and Hadassah Hospitals. Other research and studies are being conducted in other world-renowned medical centers around the globe
With our fixed algorithm, our mid-term results show that we have achieved a correlation of 96.33%.
We were also able to achieve accurate correlation to the CT (cycle threshold) value of the subjects that tested positive to COVID19.
The points on the chart represent the BOH calculations based on FTIR readings and correlated to a central line of the actual CT readings of these test results.
We chose to use the FTIR (Fourier-transform infrared spectroscopy) as our analytic system because of its availability, sensitivity, mobility and simplicity of operation thus adding another limiting factor to our choice of markers, to markers that are easily detectable by the FTIR.
Our algorithm has achieved a repeatable and stable correlation of 96.33% compared to GeneXpert Systems and NeuMoDx Molecular, Inc. PCR’s positive and negative results. We were also able to achieve accurate correlation to the CT (cycle threshold) value of the subjects that tested positive to COVID19.